Table 2.
Description of study patient population.
| Study Population Demographics and COVID-19 Risk Factors Prevalence (N = 302,125) | |
|---|---|
| Age | |
| Mean | 76 |
| Sex | |
| Female | 57% |
| Male | 43% |
| Race | |
| White | 84% |
| Black | 11% |
| Other | 2% |
| Unknown | 3% |
| COVID-19 Vulnerability | |
| High | 64% |
| Very High | 36% |
| Chronic Disease Diagnoses | |
| Cancer | 22% |
| Chronic Obstructive Pulmonary Disease | 25% |
| Cardiovascular Disease | 37% |
| Diabetes | 41% |
| Hypertension | 90% |
| BP Control | |
| Controlled | 75% |
| Uncontrolled (>160/100) | 5% |
| Unknown |
20% |
| Study Population Practice Characteristics (N = 302,125) | |
| ACO Start Year | |
| 2014 | 2% |
| 2015 | 2% |
| 2016 | 11% |
| 2017 | 19% |
| 2018 | 11% |
| 2019 | 27% |
| 2020 | 27% |
| Practice Type | |
| Private Practice | 50% |
| FQHC/RHC | 20% |
| Multispecialty | 16% |
| Other | 14% |
| Metropolitan Statistical Area (MSA) Status | |
| Metropolitan | 70% |
| Non-metropolitan | 30% |
| Practice Size (MSSP Lives Under Management) | |
| Small (0–500) | 14% |
| Medium (501–2000) | 52% |
| Large (>2000) | 34% |
| Value Based Care Penetration (mean) | 27% |
| Baseline AWV Rate (mean) | 64% |
| Local Prevalence of Influenza-like-Illness (mean) | 6% |